Financial News · Live Terminal

Page 481 of 518

Chardan Downgrades Passage Bio to Neutral From Buy, Cuts Price Target to $7 From $21

Passage Bio (PASG) has an average rating of overweight and mean price target of $18.50, according to analysts polled by FactSet.

$PASG

Research156d ago

RBC Upgrades Unilever to Sector Perform From Underperform, Keeps GBP42 Price Target

Unilever PLC's (UL) London stock has an average rating of hold and mean price target of GBP51.66, according to analysts polled by FactSet.

$UL

Research156d ago

Thanachart Securities Downgrades PTT Exploration and Production to Hold from Buy; Price Target is THB159

PTT Exploration and Production (BKK:PTTEP) has an average rating of overweight and mean price target of 164.68 baht, according to analysts polled by FactSet.

BKK:PTTEP

Research156d ago

Citi Starts Anthem BioSciences at Buy with INR870 Price Target

Anthem BioSciences (NSE:ANTHEM, BOM:544449) has an average rating of buy and mean price target of 773 Indian rupees, according to analysts polled by FactSet.

BOM:544449NSE:ANTHEM

Research156d ago

Cathay Securities Upgrades China Steel Chemical to Buy from Neutral; Price Target is NT$95

TPE:1723

Research156d ago

Berenberg Initiates Palo Alto Networks at Buy With $215 Price Target

Palo Alto Networks (PANW) has an average rating of buy and mean price target of $207.02, according to analysts polled by FactSet.

$PANW

Research156d ago

Phillips Securities Starts Shima Seiki Manufacturing at Buy with 1,700 Yen Price Target

TYO:6222

Research156d ago

Tokai Tokyo Downgrades Aidma Holdings to Neutral from Outperform; Price Target is 1,200 Yen

TYO:7373

Research156d ago

Citi Downgrades Miura to Neutral from Buy; Price Target is 3,500 Yen

TYO:6005

Research156d ago

CGS International Upgrades Kasikornbank to Add from Hold; Price Target is THB204

Kasikornbank (BKK:KBANK) has an average rating of overweight and mean price target of 202.43 baht, according to analysts polled by FactSet.

BKK:KBANK

Research156d ago

Macquarie Downgrades HUB24 to Neutral from Outperform; Price Target is AU$94.50

HUB24 (ASX:HUB) has an average rating of overweight and mean price target of AU$110.17, according to analysts polled by FactSet.

ASX:HUB

Research156d ago

Krungsri Securities Downgrades Chularat Hospital to Neutral from Buy; Price Target is THB1.60

Chularat Hospital (BKK:CHG) has an average rating of overweight and mean price target of 1.81 baht, according to analysts polled by FactSet.

BKK:CHG

Research156d ago

CMB International Starts Beijing Haizhi Technology Group at Buy with HK$84.50 Price Target

HKG:2706

Research156d ago

Phillip Securities Downgrades Betagro to Sell from Hold; Price Target is THB20.40

Betagro (BKK:BTG) has an average rating of overweight and mean price target of 22.60 baht, according to analysts polled by FactSet.

BKK:BTG

Research156d ago

Phillip Securities Upgrades Quality Houses to Accumulate from Hold; Price Target is THB1.44

Quality Houses (BKK:QH) has an average rating of hold and mean price target of 1.40 baht, according to analysts polled by FactSet.

BKK:QH

Research156d ago

Ajaib Sekuritas Asia Starts Elnusa at Buy with IDR1,100 Price Target

IDX:ELSA

Research156d ago

UOB Kay Hian Starts Beng Kuang Marine at Buy with SG$0.64 Price Target

SGX:BEZ

Research156d ago

Maybank Research Starts HRnetGroup at Buy with SG$0.87 Price Target

SGX:CHZ

Research156d ago

Canaccord Genuity Initiates Amgen at Hold With $366 Price Target

Amgen (AMGN) has an average rating of overweight and mean price target of $357.77, according to analysts polled by FactSet.

$AMGN

Research156d ago

Canaccord Genuity Initiates AbbVie at Buy With $262 Price Target

AbbVie (ABBV) has an average rating of overweight and mean price target of $255.37, according to analysts polled by FactSet.

$ABBV

Showing 9601-9620 of 10350